K-833

N/A

Report date: 2025/07/31 17:00:59
NME

Base Information

Drug NameK-833
Drug Alias NameK-833
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucose-dependent insulinotropic receptor agonists
TargetsGlucose-dependent insulinotropic receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Metabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKallyope Inc
China Registration ClassN/A

Develop Information

Active CompaniesKallyope Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2Metabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A